Global Bromhidrosis Disease Treatment Market, By Treatment (Botox, Liposuction, Surgery, Home Remedies), Complications (Trichomycosis Axillaris, Erythrasma, Intertrigo (Skin Rash), Type 2 Diabetes) - Industry Trends and Forecast to 2030.
Bromhidrosis Disease Treatment Market Analysis and Size
Bromhidrosis is foul-smelling body odour which is related to your sweat. Bromhidrosis or osmidrosis is defined by a foul odour due to a water-rich environment which supports bacteria, that is caused by an abnormal increase in perspiration (hyperhidrosis). This can be particularly strong when it happens in the axillary region (underarms). Rise in the government awareness programs about the disease will uplift the market growth, also rise in the population in some parts of the world, rise in the healthcare affordability in the U.S. and rise in the knowledge and awareness about the disease among the people are some of the crucial factors among others driving the global bromhidrosis disease treatment market growth.
Data Bridge Market Research analyses that the global bromhidrosis disease treatment market which was USD 412.12 million in 2022, is expected to reach USD 841.04 million by 2030, and is expected to undergo a CAGR of 9.32% during the forecast period of 2023 to 2030. “Home remedies” dominates the treatment segment of the global bromhidrosis disease treatment market owing to high safety and low complications. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Bromhidrosis Disease Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment (Botox, Liposuction, Surgery, Home Remedies), Complications (Trichomycosis Axillaris, Erythrasma, Intertrigo (Skin Rash), Type 2 Diabetes)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Allergan (U.S.), GALDERMA (Switzerland), Ipsen Pharma (France), Merz Pharma (Germany), Pfizer Inc (U.S.), MEDISELLER (India), Biovencer Healthcare Private Limited (India), D.S. Pharma (Japan), Wellcome Health Care (India), Medicine Impex (India), Shree Sai Healthcare (India), Caizen Health Care (India), Sri Dhanalakshmi Enterprises (India) and Medicare Pharma (India)
|
|
Market Opportunities
|
|
Market Definition
Bromhidrosis is a medical term that refers to a condition characterized by excessive and foul-smelling sweat, typically occurring in the armpits, feet, or groin area. It is often the result of bacteria breaking down sweat and producing unpleasant odours. Poor hygiene, certain medical conditions, and hormonal changes can contribute to bromhidrosis. Managing this condition usually involves maintaining good personal hygiene, using antiperspirants or deodorants, wearing breathable clothing, and, in severe cases, seeking medical intervention such as prescription-strength antiperspirants or even surgery to remove sweat glands in extreme instances.
Global Bromhidrosis Disease Treatment Market Dynamics
Drivers
- Increasing Prevalence of Effective Solutions
The growing incidence of bromhidrosis, influenced by factors such as obesity, hormonal imbalances, and genetics, leads to a larger population seeking treatment. In addition, modern lifestyles and demographic shifts, including an aging population, contribute to the rising prevalence, emphasizing the need for effective solutions.
- Technological Innovations and Advancement
Ongoing technological advancements have transformed the bromhidrosis treatment landscape. Innovative medical devices, minimally invasive procedures, and targeted therapies, such as Botox injections and microwave technology, offer more efficient and less invasive options, attracting both patients and healthcare providers alike. These innovations enhance treatment outcomes and expand the range of available solutions.
Opportunities
- Growth of Medical and Pharmaceutical Industry
With the growth of the global bromhidrosis treatment market, there's a significant opportunity for pharmaceutical companies to develop novel products such as prescription medications, antiperspirants, and surgical interventions tailored specifically to address this condition. These developments can lead to improved patient outcomes and substantial market growth.
- Growth of Cosmetics and Personal Care Industry
The cosmetics and personal care sector can seize the opportunity by formulating specialized products such as deodourants and body sprays designed to effectively manage the symptoms of bromhidrosis. Innovations in product ingredients and formulations can cater to the unique needs of individuals seeking odor control solutions.
Restraints/Challenges
- Limited Awareness among the Public
One of the significant challenges in addressing bromhidrosis is the general lack of public awareness about this condition. Many people experiencing excessive sweating and body odour may not recognize it as a medical issue, attributing it instead to poor hygiene or diet. This lack of awareness can result in delayed diagnosis and treatment, preventing affected individuals from seeking appropriate medical guidance and potentially effective solutions. Healthcare education and awareness campaigns are vital to overcome this obstacle and encourage early intervention.
- Stigma and Embarrassment to Discuss with Professionals
The social stigma associated with body odour issues can be a substantial barrier to seeking medical help for bromhidrosis. Individuals often feel embarrassed, self-conscious, and reluctant to discuss their symptoms with healthcare professionals. This stigma can lead to attempts at self-treatment using over-the-counter products that may provide only temporary relief or no relief at all. Reducing the stigma surrounding bromhidrosis through public education and awareness can help individuals overcome these emotional barriers and seek proper medical care, improving their overall quality of life.
This global bormhidrosis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global bormhidrosis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Bromhidrosis Disease Treatment Market Scope
The global bormhidrosis treatment market is segmented on the basis of treatment and complications. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Botox
- Liposuction
- Surgery
- Home Remedies
Complications
- Trichomycosis Axillaris
- Erythrasma
- Intertrigo (Skin Rash)
- Type 2 Diabetes
Global Bromhidrosis Disease Treatment Market Regional Analysis/Insights
The global bormhidrosis treatment market is analysed and market size insights and trends are provided by treatment and complications as referenced above.
The countries covered in the global bormhidrosis treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the global bormhidrosis treatment market due to changing lifestyle and increasing healthcare expenditure rise in the availability of funds for research, huge patient population, increasing healthcare expenditures, well-developed healthcare sector and government support for research & development in this region.
Asia-Pacific is the expected region in terms of growth in global bormhidrosis treatment market in the forecasted period of 2023 to 2030, due to huge patient population, and rise in the presence of huge opportunity in the market in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The global bormhidrosis treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global bormhidrosis treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global bormhidrosis treatment market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Bromhidrosis Disease Treatment Market Share Analysis
The global bormhidrosis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global bormhidrosis treatment market.
Some of the major players operating in the global bormhidrosis treatment market are:
- Allergan (U.S.)
- GALDERMA (Switzerland)
- Ipsen Pharma (France)
- Merz Pharma (Germany)
- Pfizer Inc (U.S.)
- MEDISELLER (India)
- Biovencer Healthcare Private Limited (India)
- D.S. Pharma (Japan)
- Wellcome Health Care (India)
- Medicine Impex (India)
- Shree Sai Healthcare (India)
- Caizen Health Care (India)
- Sri Dhanalakshmi Enterprises (India)
- Medicare Pharma (India)
SKU-